Advisory Team

The Advisory Team at Equillium provides strategic guidance and expert insights to drive the development and clinical advancement of innovative therapies targeting severe autoimmune and inflammatory diseases. The team comprises experienced professionals, including advisors and senior executives such as the Chief Development Officer and Chief Medical Officer, who collaborate to shape and oversee the company’s research, clinical, and operational strategies to meet high unmet medical needs.